argenx SE | ARGX - Ebit

Stock Price
718.60
Daily Change
5.00 0.70%
Monthly
5.12%
Yearly
13.81%
Q1 Forecast
686.63

argenx SE reported $349.97M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AstraZeneca USD -1.5B 5.01B Sep/2025
Galapagos EUR -41.67M 15.35M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Qiagen NV USD 141.06M 6.64M Sep/2025
UCB EUR 502M 168M Dec/2024